recombinant tissue plasminogen activatoracute ischaemic strokethrombolytic therapyNINDSStroke
…rs and Stroke (NINDS) trial in 1995, which formally established recombinant tissue plasminogen activator as an effective treatment for stroke. This evolution has occurr…